PRECISION OPTICS CORPORATION, INC. (POCI)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
03.10.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office
20.03.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Offic
04.03.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Offic
15.06.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office
09.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office
05.01.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC              Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Office

Stammdaten

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Unternehmen & Branche

NamePRECISION OPTICS CORPORATION, INC.
TickerPOCI
CIK0000867840
BoerseUS
SektorHealthcare
IndustrieMedical - Instruments & Supplies
SIC3845 · Electromedical & Electrotherapeutic Apparatus

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung32,3 Mio. USD
Beta0,33
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-Q7,367,837-1,780,791-0.2322,895,5539,329,734
2025-09-3010-Q6,680,823-1,637,030-0.2122,384,93010,923,443
2025-06-3010-K19,091,269-5,780,246-0.8519,790,28712,258,834
2025-03-3110-Q4,185,968-2,096,761-0.3019,622,27413,177,717
2024-12-3110-Q4,526,907-969,681-0.1517,510,5919,475,972
2024-09-3010-Q4,197,053-1,311,247-0.2117,238,66110,137,447
2024-06-3010-K19,104,350-2,951,377-0.4916,912,57410,067,788
2024-03-3110-Q5,242,579-317,055-0.0518,271,82511,261,111
2023-12-3110-Q4,824,289-758,802-0.1317,697,37611,317,252
2023-09-3010-Q4,321,255-464,415-0.0819,068,48411,690,923
2023-06-3010-K21,044,467-144,613-0.0319,740,43412,046,592
2023-03-3110-Q5,048,065-398,432-0.0718,186,6439,697,897
2022-12-3110-Q5,886,961508,6680.0917,469,2419,641,215
2022-09-3010-Q5,085,301-158,724-0.0317,167,8328,887,761
2022-06-3010-K15,678,248-928,416-0.1816,704,0208,971,495
2022-03-3110-Q4,651,352-113,899-0.0217,267,0048,528,341
2021-12-3110-Q3,897,041-507,013-0.0916,888,7479,189,485
2021-09-3010-Q2,336,344-576,801-0.047,101,9254,034,397
2021-06-3010-K10,674,907-102,835-0.016,261,3003,431,127
2021-03-3110-Q2,458,290552,2780.045,905,9753,453,901

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-03-30COLL WAYNE MOfficer, Chief Financial OfficerOpen Market Purchase20,8333.6074,998.80+97,8%
2026-03-30Forkey Joseph NormanDirector, Officer, Chief Executive OfficerOpen Market Purchase1,3883.604,996.80+6,5%
2026-03-30TRAUT JOSEPHOfficer, Chief Operating OfficerOpen Market Purchase41,6663.60149,997.60+195,7%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×